2010
Evaluating Interventions to Improve Antiretroviral Adherence: How Much of an Effect Is Required for Favorable Value?
Braithwaite RS, Fiellin DA, Nucifora K, Bryant K, Roberts M, Kim N, Justice AC. Evaluating Interventions to Improve Antiretroviral Adherence: How Much of an Effect Is Required for Favorable Value? Value In Health 2010, 13: 535-542. PMID: 20345544, PMCID: PMC3032536, DOI: 10.1111/j.1524-4733.2010.00714.x.Peer-Reviewed Original ResearchConceptsAbsolute risk reductionNonadherent patientsAdherence interventionsRelative riskRisk factorsAntiretroviral therapy adherence interventionsEffect sizeNonadherence risk factorsBehavioral risk factorsHIV careAntiretroviral adherencePatientsNonadherenceSocietal perspectiveIncremental costIntervention costsSmall effect sizesLife expectancyInterventionRisk reductionPlausible effect sizes
2008
Factor Structure of Leigh’s (1990) Alcohol Sex Expectancies Scale in Individuals in Treatment for HIV Disease
Maisto SA, McGinnis K, Cook R, Conigliaro J, Bryant K, Justice AC. Factor Structure of Leigh’s (1990) Alcohol Sex Expectancies Scale in Individuals in Treatment for HIV Disease. AIDS And Behavior 2008, 14: 174-180. PMID: 18791863, PMCID: PMC3032495, DOI: 10.1007/s10461-008-9457-2.Peer-Reviewed Original ResearchConceptsHIV groupHIV-positive adultsGeneral medicine clinicSexual risk reductionExcellent internal consistency reliabilityHIV diseaseMedicine clinicInternal consistency reliabilityInfectious diseasesFurther scale refinementHIVReduced inhibitionClinical samplesPrincipal component factor analysisRisk reductionConsistency reliabilityTreatmentDiseaseConstruct validityTotal sampleComponent factor analysisSexMenGroupFactor analysis